secwatch / observer
8-K filed July 21, 2022, 7:59 PM ET ticker NEO CIK 0001077183
leadership confidence high sentiment positive materiality 0.65

NeoGenomics appoints Chris Smith as CEO effective Aug 15, 2022; Tetrault resumes Chair

NEOGENOMICS INC

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Chris Smith

Chief Executive Officer
NEO · NEOGENOMICS INC
Effective
2022-08-15
Filed
July 21, 2022, 7:59 PM ET
On July 21, 2022, NeoGenomics, Inc. (the “Company”) announced that Chris Smith, age 59, was appointed Chief Executive Officer and a member of the board of directors of the Company, effective August 15, 2022 (the “Effective Date”).
Role change

Lynn Tetrault

Chair of the Board
NEO · NEOGENOMICS INC
Effective
2022-08-15
Successor
Chris Smith
Filed
July 21, 2022, 7:59 PM ET
In connection with Mr. Smith’s appointment, Lynn Tetrault, Esq. will step down as Interim Chief Executive Officer of the Company and will resume the position of independent Chair of the Board effective August 15, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Chris Smith was appointed as Chief Executive Officer at NEOGENOMICS INC.

Action
appointed
Role
Chief Executive Officer
Exact text from the filing
On July 21, 2022, NeoGenomics, Inc. (the “Company”) announced that Chris Smith, age 59, was appointed Chief Executive Officer and a member of the board of directors of the Company, effective August 15, 2022 (the “Effective Date”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Lynn Tetrault changed role as Chair of the Board at NEOGENOMICS INC.

Action
step down as Interim CEO and resume Chair
Role
Chair of the Board
Exact text from the filing
In connection with Mr. Smith’s appointment, Lynn Tetrault, Esq. will step down as Interim Chief Executive Officer of the Company and will resume the position of independent Chair of the Board effective August 15, 2022.
View on SEC.gov

NEOGENOMICS INC filing history →

Source: SEC EDGAR
accession 0001077183-22-000124
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.